Xue-Lin Zhang1, Jun-Hong Chen2, Cheng-Kun Qin3. 1. Department of General Surgery, Shandong Provincial Hospital, Shandong UniversityJinan 250021, Shandong, China; Department of General Surgery, Liaocheng People's HospitalLiaocheng 252000, Shandong, China. 2. Department of General Surgery, Liaocheng People's Hospital Liaocheng 252000, Shandong, China. 3. Department of General Surgery, Shandong Provincial Hospital, Shandong University Jinan 250021, Shandong, China.
Abstract
BACKGROUND: MicroRNA-155 (miR-155) is over-expressed in both hematopoietic malignancies and solid tumors. In the present study, we investigated the clinical significance of miR-155 in gallbladder carcinoma among Chinese population. METHODS: Tissue specimens were collected from 133 patients who had undergone surgical resection at Shandong Provincial Hospital, Shandong University between May 2008 and April 2014. We profiled miR- 155 expression in the gallbladder carcinoma tissues and normal gallbladder tissues by qRT-PCR. The Kaplan-Meier method was used to analyze the 5-year survival rate. RESULTS: The expression levels of miR-155 were significantly higher in gallbladder carcinoma tissues than that in normal gallbladder tissues (P<0.001). High miR-155 expression was significantly associated with TNM stage (P=0.003), lymph node status (P=0.042), liver metastasis (P=0.010), and differentiated degree (P<0.001). We found that gallbladder carcinoma patients with high miR-155 expression level had distinctly shorter overall survival than patients with low miR-155 expression level (P=0.03). Multivariate analysis revealed that miR-155 expression level was independent prognostic factors for overall survival (HR=2.394, 95% CI: 1.568-10.034; P=0.009). CONCLUSION: High miR-155 expression is a prognostic indicator for poor prognosis of patients with gallbladder carcinoma among Chinese population.
BACKGROUND:MicroRNA-155 (miR-155) is over-expressed in both hematopoietic malignancies and solid tumors. In the present study, we investigated the clinical significance of miR-155 in gallbladder carcinoma among Chinese population. METHODS: Tissue specimens were collected from 133 patients who had undergone surgical resection at Shandong Provincial Hospital, Shandong University between May 2008 and April 2014. We profiled miR- 155 expression in the gallbladder carcinoma tissues and normal gallbladder tissues by qRT-PCR. The Kaplan-Meier method was used to analyze the 5-year survival rate. RESULTS: The expression levels of miR-155 were significantly higher in gallbladder carcinoma tissues than that in normal gallbladder tissues (P<0.001). High miR-155 expression was significantly associated with TNM stage (P=0.003), lymph node status (P=0.042), liver metastasis (P=0.010), and differentiated degree (P<0.001). We found that gallbladder carcinomapatients with high miR-155 expression level had distinctly shorter overall survival than patients with low miR-155 expression level (P=0.03). Multivariate analysis revealed that miR-155 expression level was independent prognostic factors for overall survival (HR=2.394, 95% CI: 1.568-10.034; P=0.009). CONCLUSION: High miR-155 expression is a prognostic indicator for poor prognosis of patients with gallbladder carcinoma among Chinese population.
Authors: J Khalife; H S Radomska; R Santhanam; X Huang; P Neviani; J Saultz; H Wang; Y-Z Wu; H Alachkar; M Anghelina; A Dorrance; J Curfman; C D Bloomfield; B C Medeiros; D Perrotti; L J Lee; R J Lee; M A Caligiuri; F Pichiorri; C M Croce; R Garzon; M L Guzman; J H Mendler; G Marcucci Journal: Leukemia Date: 2015-05-14 Impact factor: 11.528
Authors: Jana Merhautova; Renata Hezova; Alexandr Poprach; Alena Kovarikova; Lenka Radova; Marek Svoboda; Rostislav Vyzula; Regina Demlova; Ondrej Slaby Journal: Biomed Res Int Date: 2015-05-03 Impact factor: 3.411
Authors: Katrien Van Roosbroeck; Francesca Fanini; Tetsuro Setoyama; Cristina Ivan; Cristian Rodriguez-Aguayo; Enrique Fuentes-Mattei; Lianchun Xiao; Ivan Vannini; Roxana S Redis; Lucilla D'Abundo; Xinna Zhang; Milena S Nicoloso; Simona Rossi; Vianey Gonzalez-Villasana; Rajesha Rupaimoole; Manuela Ferracin; Fortunato Morabito; Antonino Neri; Peter P Ruvolo; Vivian R Ruvolo; Chad V Pecot; Dino Amadori; Lynne Abruzzo; Steliana Calin; Xuemei Wang; M James You; Alessandra Ferrajoli; Robert Orlowski; William Plunkett; Tara M Lichtenberg; Ramana V Davuluri; Ioana Berindan-Neagoe; Massimo Negrini; Ignacio I Wistuba; Hagop M Kantarjian; Anil K Sood; Gabriel Lopez-Berestein; Michael J Keating; Muller Fabbri; George A Calin Journal: Clin Cancer Res Date: 2016-11-30 Impact factor: 12.531